Novartis Investigative Site

Nakagami, Okinawa 903 0215

0 studies enrolling now · 1 studies all time

What they study most

Hidradenitis Suppurativa

Studies at this site

• This Was a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS). — Completed